2016
DOI: 10.1016/j.jacc.2016.04.035
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Amyloid Load

Abstract: Early identification of subjects with AL amyloid is essential given that in late-stage disease with extensive amyloid load, our data suggested that outcomes are not affected by administration of chemotherapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 80 publications
(23 citation statements)
references
References 42 publications
0
21
0
1
Order By: Relevance
“…Mean arterial pressure is a predictor of mortality in the THAOS database among patients in the United States [36]. Low blood pressure has also been associated with greater mortality in patients with light-chain cardiac amyloidosis [16,37] as well as heart failure with reduced ejection fraction [38,39]. Decreases in arterial blood pressure may represent worsening amyloid with lower cardiac stroke volume or even the effects of progressive autonomic dysfunction in effected individuals [40].…”
Section: Discussionmentioning
confidence: 99%
“…Mean arterial pressure is a predictor of mortality in the THAOS database among patients in the United States [36]. Low blood pressure has also been associated with greater mortality in patients with light-chain cardiac amyloidosis [16,37] as well as heart failure with reduced ejection fraction [38,39]. Decreases in arterial blood pressure may represent worsening amyloid with lower cardiac stroke volume or even the effects of progressive autonomic dysfunction in effected individuals [40].…”
Section: Discussionmentioning
confidence: 99%
“…transplantation, dialysis, and occasionally, organ transplantation [12,15]. Median survival of systemic AL amyloidosis with cardiac involvement is 15.7 months [16].…”
Section: G H -D O S E C H E M O T H E R a P Y A U T O L O G O U S mentioning
confidence: 99%
“…Unfortunately, all of our patients had advanced disease with high amyloid burden and concomitant systolic dysfunction. When myocardial amyloid burden reaches a certain threshold, cardiac damage is known to become irreversible and chemotherapy does not appear to improve outcomes [ 17 ]. Two of our 3 patients had cerebral ischemic events despite sinus rhythm.…”
Section: Discussionmentioning
confidence: 99%